1. Beals JM, Cutler GB, Doyle B, Hansen RJ, Li S, Shirani S, Zhang L (2009) inventors, Eli Lilly and Company, assignee. Pegylated insulin lispro compounds. International patent WO 20091521128 A1. 2009 Dec 17.
2. Evidence for metabolic cleavage of a PEGylated protein in vivo using multiple analytical methodologies;Elliott;Mol Pharm,2012
3. The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
4. Humalog (1996) Package insert. Eli Lilly and Company, Indianapolis, IN.
5. Kiselyov VV, Moyers JS, Volk CB, Cao JXC, Wu GY, Ding L, and Michael DM(2014). Binding kinetics, internalisation and localisation of long-acting basal insulin peglispro (BIL) and insulin receptor in cells. Presented at 2014 EASD Meeting in Vienna, Austria. Abstract 971.